Antibacterial activity of clarithromycin loaded PLGA nanoparticles

Pharmazie

Volumn 67, Issue 1, 2012, Pages 63-68

  Valizadeh, H ^a,b   Mohammadi, G ^c   Ehyaei, R ^a   Milani, M ^a   Azhdarzadeh, M ^a   Zakeri Milani, P ^a   Lotfipour, Farzaneh ^a,d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; NANOPARTICLE; POLYGLACTIN; ANTIINFECTIVE AGENT; EXCIPIENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG ADSORPTION; DRUG DEGRADATION; DRUG FORMULATION; DRUG POTENCY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; SUSPENSION;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ESCHERICHIA COLI; EXCIPIENTS; HAEMOPHILUS INFLUENZAE; LACTIC ACID; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUSPENSIONS;

EID: 84858766370     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1052     Document Type: Article

References (31)

1. Abeylath SC, Turos E, Dickey S, Lim DV (2008) Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem 16: 2412-2418.
2. Barrera DA, Zylstra E, Lansbury Jr PT, Langer R (1993) Synthesis and RGD peptide modification of a new biodegradable copolymer: Poly(lactic acid-co-lysine). J Am Chem Soc 115: 11010-11011.
3. Cavallaro G, Fresta M, Giammona G, Puglisi G. Villari A (1994) Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system. Int J Pharm 111: 31-41.
4. Cheow WS, Hadinoto K (2010) Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods. Coll Surf A: Physicochem Eng Aspects 370: 87-79.
5. Diezz S, de Ilarduya TC (2006) Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 63: 188-197.
6. Dillen K, Bridts C, Van der Veken P, Cos P, Vandervoort J, Augustyns K, Stevens W, Ludwig A (2008) Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas. Int J Pharm 349: 234-240.
7. Dillen K, Vandervoort J, Van Den Mooter G, Verheyden L, Ludwig A (2004) Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 275: 171-187.
8. Erah PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC (1997) The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother 39: 5-12.
9. Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R (2007) Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomed Nanotechnol Biol Med 3: 161-167.
10. Fattal E, Rojas J, Youssef M, Couvreur P. Andremont A (1991) Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrob Agents Chemother 35: 770-772.
11. Fawaz F, Bonini F, Maugein J, Lagueny AM (1998) Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: Pharmacokinetics and in vitro antimicrobial activity. Int J Pharm 168: 255-259.
12. Gu H, Ho PL, Tong E, Wang L, Xu B (2003) Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 3: 1261-1263.
13. Heller J (1980) Controlled release of biologically active compounds from bioerodible polymers. Biomaterials 1: 51-57.
14. Henry-Michelland S, Alonso MJ, Andremont A (1987) Attachment of antibiotics to nanoparticles: Preparation, drug-release and antimicrobial activity in vitro. Int J Pharm 35: 121-127.
15. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG (2011) Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77: 407-416.
16. Jain RA (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490.
17. Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW (2008) Ciprofloxacin-encapsulated poly(dl-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm 352: 317-323.
18. Kell AJ, Stewart G, Ryan S, Peytavi R, Boissinot M, Huletsky A, Bergeron MG, Simard B (2008) Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria. ACS Nano 2: 1777-1788.
19. Mohammadi G, Valizadeh H, Barzegar-Jalali M, Lotfipour F, Adibkia K, Milani M, Azhdarzadeh M, Kiafar F, Nokhodchi A (2010) Development of azithromycin-PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi. Coll Surf B: Biointerfaces 80: 34-39.
20. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y (2000) Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technol 107: 137-143.
21. NCCLS (1996) Performance standards for antimicrobial disk susceptibility tests: Approved Standard M2-A6. Wayne, PA, National Committee for Clinical Laboratory Standards.
22. NCCLS(2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, PA, National Committee for Clinical Laboratory Standards.
23. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 55: 329-347.
24. PDR (2007) Physicianǐs Desk Reference Mont Vale NJ, Thompson PDR.
25. Pinto-Alphandary H, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int J Antimicrob Agents 13: 155-168.
26. Sohn YT, Rhee JK, Im WB (2000) Polymorphism of clarithromycin. Arch Pharm Res 23: 381-384.
27. Turos E, Reddy GSK, Greenhalgh K, Ramaraju P, Abeylath SC, Jang S, Dickey S, Lim DV (2007a) Penicillin-bound polyacrylate nanoparticles: Restoring the activity of β-lactam antibiotics against MRSA. Bioorg Med Chem Lett 17: 3468-3472.
28. Turos E, Shim JY, Wang Y, Greenhalgh K, Reddy GSK, Dickey S, Lim DV (2007b) Antibiotic-conjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 17: 53-56.
29. Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh- Bahreini MA, Adibkia K, Nokhodchi A (2007) Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Devel Ind Pharm 33: 45-56.
30. Zakeri-Milani P, Valizadeh H, Ghanbarzadeh S, Nemati M (2009) Pharmacokinetics and comparative bioavailability study of two clarithromycin suspensions following administration of a single oral dose to healthy volunteers. Arzneimittel-Forsch/Drug Res 59: 429-432.
31. Zhang L, Pornpattananangkul D, Hu CMJ, Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17: 585-594.